Search

Your search keyword '"Ku, Ja Hyeon"' showing total 1,371 results

Search Constraints

Start Over You searched for: Author "Ku, Ja Hyeon" Remove constraint Author: "Ku, Ja Hyeon"
1,371 results on '"Ku, Ja Hyeon"'

Search Results

2. Preoperative smoking and robot-assisted radical cystectomy outcomes & complications in multicenter KORARC database

3. A dietary commensal microbe enhances antitumor immunity by activating tumor macrophages to sequester iron

9. Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer

14. MP44-10 RISK FACTORS OF RENAL CELL CARCINOMA LATE RECURRENCE: KORCC REGISTRY ANALYSIS

15. MP36-18 ARTIFICIAL INTELLIGENCE BASED PERSONALIZED ONCOLOGICAL OUTCOME PREDICTION MODEL FOR UPPER URINARY TRACT UROTHELIAL CARCINOMA AFTER RADICAL NEPHROURETERECTOMY: DEVELOPMENT AND MULTI-CENTER VALIDATION

16. PD48-02 FIRST SAFETY AND EFFICACY RESULTS OF THE TAR-210 ERDAFITINIB INTRAVESICAL DELIVERY SYSTEM IN PATIENTS WITH NON–MUSCLE-INVASIVE BLADDER CANCER WITH SELECT FGFR ALTERATIONS

20. Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma

21. CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer

24. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score–Matched Analysis

25. Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma

26. Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma

34. Adrenal Tumors

35. Retroperitoneal Tumors

36. Urothelial Tumors

46. Urine-based testing for patient selection and genomic characterization of patients with FGFR alteration-positive non–muscle-invasive bladder cancer (NMIBC) treated with TAR-210.

47. Risk stratification and management of non‐muscle‐invasive bladder cancer: A physician survey in six Asia‐Pacific territories.

48. Controversies in terminology associated with management of BCG‐unresponsive NMIBC in Asia‐Pacific.

Catalog

Books, media, physical & digital resources